Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Saima Jamil Farooqi"'
Autor:
Vilde Drageset Haakensen, Anna K. Nowak, Espen Basmo Ellingsen, Saima Jamil Farooqi, Maria Moksnes Bjaanæs, Henrik Horndalsveen, Tine Mcculloch, Oscar Grundberg, Susana M. Cedres, Åslaug Helland
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive tumour. For patients with inoperable disease, few treatment options are available after first line chemotherapy. The combination of ipilimumab and nivolumab has recentl
Externí odkaz:
https://doaj.org/article/64fe1d0ba38a4b3f9fc9f05cfd5c3739
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 141
Autor:
Åslaug Helland, Vilde Drageset Haakensen, Maria Moksnes Bjaanæs, Saima Jamil Farooqi, Espen Basmo Ellingsen, Anna K. Nowak, Oscar Grundberg, Henrik Horndalsveen, Tine McCulloch, Susana Cedres
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-9 (2021)
Haakensen, V D, Nowak, A K, Ellingsen, E B, Farooqi, S J, Bjaanæs, M M, Horndalsveen, H, Mcculloch, T, Grundberg, O, Cedres, S M & Helland, Å 2021, ' NIPU : a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma ', Journal of Translational Medicine, vol. 19, no. 1, 232 . https://doi.org/10.1186/s12967-021-02905-3
Journal of Translational Medicine
Scientia
Haakensen, V D, Nowak, A K, Ellingsen, E B, Farooqi, S J, Bjaanæs, M M, Horndalsveen, H, Mcculloch, T, Grundberg, O, Cedres, S M & Helland, Å 2021, ' NIPU : a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma ', Journal of Translational Medicine, vol. 19, no. 1, 232 . https://doi.org/10.1186/s12967-021-02905-3
Journal of Translational Medicine
Scientia
Background Malignant pleural mesothelioma (MPM) is a rare and aggressive tumour. For patients with inoperable disease, few treatment options are available after first line chemotherapy. The combination of ipilimumab and nivolumab has recently shown i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1414c05d37719c0f46f3778385b64a97
http://hdl.handle.net/10852/86272
http://hdl.handle.net/10852/86272
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Maria Moksnes Bjaanæs, C.W. Langberg, Saima Jamil Farooqi, Vilde Drageset Haakensen, H. Horndalsveen, H.M. Nymoen, Åslaug Helland
Publikováno v:
Journal of Thoracic Oncology. 16:S1045
Autor:
E. Ellingsen, Vilde Drageset Haakensen, Saima Jamil Farooqi, Susana Cedres, Anna K. Nowak, Åslaug Helland, Tine McCulloch, O. Grundberg, Maria Moksnes Bjaanæs
Publikováno v:
Journal of Thoracic Oncology. 16:S380